Portola Pharmaceuticals
PTLA
#5420
Rank
ยฃ1.04 B
Marketcap
ยฃ13.35
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Revenue for Portola Pharmaceuticals (PTLA)

Revenue in 2020 (TTM): ยฃ95.9 Million

According to Portola Pharmaceuticals 's latest financial reports the company's current revenue is ยฃ89.49 Million. In 2019 the company made a revenue of ยฃ86.36 Million an increase over the revenue in the year 2018 that were of ยฃ29.71 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Portola Pharmaceuticals from 2012 to 2020

Annual revenue

Year Revenue Change
2020 (TTM)ยฃ95.9 M11.04%
2019ยฃ86.36 M190.66%
2018ยฃ29.71 M77.99%
2017ยฃ16.69 M-36.5%
2016ยฃ26.28 M194.15%
2015ยฃ8.93 M25.39%
2014ยฃ7.12 M-8.6%
2013ยฃ7.79 M-85.38%
2012ยฃ53.34 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
ยฃ68.23 B 76,144.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ46.49 B 51,849.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ35.19 B 39,222.42%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
ยฃ7.45 B 8,228.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ35.56 B 39,643.50%๐Ÿ‡บ๐Ÿ‡ธ USA